Actinium Pharmaceuticals, Inc. (ATNM) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.09 | +14.2% |
| 2024 | $-1.27 | +30.6% |
| 2023 | $-1.83 | -33.6% |
| 2022 | $-1.37 | -14.2% |
| 2021 | $-1.20 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.09 | +14.2% |
| 2024 | $-1.27 | +30.6% |
| 2023 | $-1.83 | -33.6% |
| 2022 | $-1.37 | -14.2% |
| 2021 | $-1.20 | — |